Evidence map›Paper›PMID 30504833›Full record

ArticleScientific reports2018

Lactobacillus reuteri HCM2 protects mice against Enterotoxigenic Escherichia coli through modulation of gut microbiota.

Tianwei Wang, Kunling Teng, Gang Liu, Yayong Liu, Jie Zhang, Xin Zhang, Min Zhang, Yong Tao, Jin Zhong

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. The Role of ProbioticsInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Frontiers in microbiology · 2025
    Article
  4. Review
  5. Article
  6. Frontiers in microbiology · 2024
    Article
  7. Article
  8. Control ofMicrobiology spectrum · 2023
    Article
  9. Article
  10. Article
  11. Vitamin BMicrobiome · 2023
    Article
  12. The role of potential probiotic strainsFrontiers in microbiology · 2023
    Review
  13. Frontiers in cellular and infection microbiology · 2023
    Review
  14. Microorganisms · 2022
    Article
  15. A Novel ProbioticMicrobiology spectrum · 2022
    Article
  16. Article
  17. Dietary supplementation ofFrontiers in microbiology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Tianwei WangState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Kunling TengState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Gang LiuKey Laboratory of Agro-Ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Hunan, 410125, China.
Yayong LiuState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Jie ZhangState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Xin ZhangLongDa Foodstuff Group Co., Ltd, Shandong Province, Laiyang, 265231, China.
Min ZhangLongDa Foodstuff Group Co., Ltd, Shandong Province, Laiyang, 265231, China.
Yong TaoState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Jin ZhongState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. zhongj@im.ac.cn.
Chinese Academy of Sciences · CNUniversity of Chinese Academy of Sciences · CNInstitute of Microbiology · CNInstitute of Subtropical Agriculture · CNMicrobiology Institute of Shaanxi · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31570114National Natural Science Foundation of China (National Science Foundation of China) 31772642
6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) is a leading cause of infectious diarrhea in children and postweaning piglets. ETEC infection results in induced pro-inflammatory responses in intestinal epithelial cells and dysbiosis of intestinal microbiota. Here, a Lactobacillus reuteri strain, HCM2, isolated from a healthy piglet showed a high survival rate in the harsh gastrointestinal tract environment and inhibited the growth of ETEC and its adherence to intestinal epithelial cells. Pre-supplementation with L. reuteri HCM2 for 14 days reduced the ETEC load in the jejunum of ETEC-infected mice and prevented the disruption of intestinal morphology by ETEC. The colonic microbiota of mice with or without HCM2 pre-supplementation were analyzed, and this analysis revealed that HCM2 could prevent dysbiosis caused by ETEC infection by stabilizing the relative abundance of dominant bacteria. These results indicate that L. reuteri HCM2 has the potential to attenuate the effect of ETEC on the colonic microbiota in infected mice.

Indexed as

Gastrointestinal MicrobiomeAnimalsBacterial AdhesionBacterial ProteinsEnterotoxigenic Escherichia coliIntestinal MucosaLimosilactobacillus reuteriMiceBacterial Proteins

Identifiers

PMID30504833
PMCPMC6269427
OpenAlexW2903054223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.